| Glioblastoma as an age-related neurological disorder in adults M Kim, E Ladomersky, A Mozny, M Kocherginsky, K O’Shea, ZZ Reinstein, ... Neuro-oncology advances 3 (1), vdab125, 2021 | 54 | 2021 |
| Overcoming immunosuppression in bone metastases ZZ Reinstein, S Pamarthy, V Sagar, R Costa, SA Abdulkadir, FJ Giles, ... Critical reviews in oncology/hematology 117, 114-127, 2017 | 37 | 2017 |
| Macrophage Toll-like receptor-chimeric antigen receptors (MOTO-CARs) as a novel adoptive cell therapy for the treatment of solid malignancies EJ Velazquez, JE Lattin, TD Brindley, ZZ Reinstein, R Chu, L Liu, ... Cancer Research 78 (13_Supplement), 2563-2563, 2018 | 15 | 2018 |
| combining anti-androgen therapy and PARP inhibition results in synergistic cytotoxicity of metastatic castration-resistant prostate cancer (mCRPC) cells S Pamarthy, V Sagar, RJ Vatapalli, Z Reinstein, MZ Ansari, BAC Filho, ... Cancer Research 77 (13_Supplement), 1114-1114, 2017 | 1 | 2017 |
| 297 Expanded genomic landscape of merkel cell carcinoma identifies new drivers Y Zhang, Z Reinstein, K Qiu, J Jackson, M Nichols, H Liu, K Tsai, J Choi Journal of Investigative Dermatology 143 (5), S51, 2023 | | 2023 |
| YIA22-002: A Common Polymorphism in 3β-Hydroxysteroid Dehydrogenase Promotes Resistance to Radiotherapy in Prostate Cancer S Ganguly, Z Lone, A Muskara, A Kondratova, A Ghanem, YM Chung, ... Journal of the National Comprehensive Cancer Network 20 (3.5), YIA22-002 …, 2022 | | 2022 |
| YIA22-004: The Feasibility of a Digitized Peer-To-Peer Patient Support System for Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation K Kirtane, J Muzaffar, J Kish, LB Oswald, BD Gonzalez, T Welniak, ... Journal of the National Comprehensive Cancer Network 20 (3.5), YIA22-004 …, 2022 | | 2022 |
| YIA22-007: Adaptive Nutrition and Exercise Weight loss (A-NEW) Study for Breast Cancer Survivors With Overweight or Obesity JY Sheng, A Montanari, F Too, M Zahurak, GL Rosner, KA Gudzune, ... Journal of the National Comprehensive Cancer Network 20 (3.5), YIA22-007 …, 2022 | | 2022 |
| YIA22-008: Identification of Biomarkers That Predict Responses to Immunotherapy in Merkel Cell Carcinoma Y Zhang, ZZ Reinstein, J Jackson, KY Tsai, J Choi, B Hu, JL Patel, R Tao, ... Journal of the National Comprehensive Cancer Network 20 (3.5), YIA22-008 …, 2022 | | 2022 |
| Talazoparib, a second generation PARP inhibitor, is a novel therapy for PTEN mutants in prostate cancer ZZ Reinstein, R Vatapalli, J Anker, S Pamarthy, B Carneiro, S Abdulkadir Cancer Research 77 (13_Supplement), 1230-1230, 2017 | | 2017 |
